BAYQ3939
Drug timelines are a Plus or Pro feature.
2 regulatory and trial events tracked for BAYQ3939, covering 2014-12-19 to 2015-04-27. Get the full timeline:
Most recent: Clinical Trial Update: A Phase III Study to Evaluate the Safety, Efficacy and Pharmacokinetics/Pharmacodynamics of BAYQ3939 in Patients With Bacterial Pneumonia [Phase 3]